- CHAMPION-AF Trial Finds LAAC an Alternative for NOAC in Lower-Risk Patients Medscape
- CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints PR Newswire
- New Frontiers in AFib: Heart Device Noninferior to Blood Thinners in Stroke Prevention, Wins on Safety pharmacytimes.com
- Treating AFib with a single procedure proves to be safer, more effective News4JAX
- Six Reasons Why CHAMPION-AF Should Not Change Practice Medscape
Related Posts
Science shows different psychiatric disorders might have same cause
A sweeping new study of psychiatric and genetic records has the potential to change treatment for millions of psychiatric patients, finding that many conditions involve […]
New mechanism links Epstein-Barr virus to MS
Image: Caption: Tomas Olsson. Photo: Andreas Andersson “The discovery opens up new treatments that target these cross-reactive immune cells. Since several EBV vaccines and antiviral […]
ODH Urges Parents to Protect Their Kids Following State’s First Pediatric Flu Death of Season
(COLUMBUS, Ohio) — The Ohio Department of Health (ODH) today is reporting the state’s first flu-associated pediatric death of the 2025-26 flu season, a teenager […]